Diarylureas: New Promising Small Molecules against Streptococcus mutans for the Treatment of Dental Caries.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Iacopetta, Domenico
  • Ceramella, Jessica
  • Catalano, Alessia
  • D'Amato, Assunta
  • Lauria, Graziantonio
  • Saturnino, Carmela
  • Longo, Pasquale
  • Sinicropi, Maria Stefania

Grupos

Abstract

Dental caries is a biofilm-mediated disease that represents a worldwide oral health issue. Streptococcus mutans has been ascertained as the main cariogenic pathogen responsible for human dental caries, with a high ability to form biofilms, regulated by the quorum sensing. Diarylureas represent a class of organic compounds that show numerous biological activities, including the antimicrobial one. Two small molecules belonging to this class, specifically to diphenylureas, BPU (1,3-bis[3,5-bis(trifluoromethyl)phenyl]urea) and DMTU (1,3-di-m-tolyl-urea), showed interesting results in studies regarding the antimicrobial activity against the cariogenic bacterium S. mutans. Since there are not many antimicrobials used for the prevention and treatment of caries, further studies on these two interesting compounds and other diarylureas against S. mutans may be useful to design new effective agents for the treatment of caries with generally low cytotoxicity.

Datos de la publicación

ISSN/ISSNe:
2079-6382, 2079-6382

ANTIBIOTICS-BASEL  Multidisciplinary Digital Publishing Institute (MDPI)

Tipo:
Article
Páginas:
-
Factor de Impacto:
0,785 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 1

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Streptococcus mutans; Streptococcus sobrinus; antimicrobials; biofilms; bis-aryl ureas; dental caries; diarylureas; diphenylureas; quorum sensing

Campos de estudio

Proyectos asociados

ESTRATEGIA INTEGRADA DE FOTODIAGNOSTICO COMBINANDO EVALUACION CLINICA, ENSAYOS BIOLOGICOS Y ESTUDIOS MECANISTICOS.

Investigador Principal: INMACULADA ANDREU ROS

PI16/01877 . INSTITUTO DE SALUD CARLOS III . 2017

Fotoalergia y fotocarcinogénesis debida a metabolitos y a fotoproductos de xenobióticos diana.

Investigador Principal: INMACULADA ANDREU ROS

ACIF/2018/153 . 2018

TEX4IRAS. Tejidos fotodinámicamente activos para prevenir las infecciones relacionadas con la asistencia sanitaria

Investigador Principal: INMACULADA ANDREU ROS

INNEST/2021/28 . AGENCIA VALENCIANA DE LA INNOVACION (AVI) . 2021

Validación y transferencia tecnológica de tejidos fotoactivos para reducir las enfermedades nosocomiales.

Investigador Principal: INMACULADA ANDREU ROS

CIAPOT/2021/33 . CONSELLERIA DE INNOVACIÓN, UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL . 2022

Cita

Compartir